Literature DB >> 2638628

Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy.

B Falsini1, V Porciatti, G Scalia, S Caputo, A Minnella, M A Di Leo, G Ghirlanda.   

Abstract

Steady-state pattern electroretinogram (PERG) in response to sinusoidal gratings (1.7 c/deg spatial frequency; 9 x 9 deg field size) temporally modulated (sinusoidally) at 8 Hz were recorded in 40 insulin-dependent diabetics and 28 age-matched normal subjects. Visual acuity was greater than or equal to 20/20 in all 40 patients; 31 (62 eyes) showed no sign of retinopathy and nine (18 eyes) showed a few microaneurysms on fluorescein angiography. Insulin-dependent diabetics showed a significant reduction in the PERG mean amplitude as compared with age-matched control subjects (one-way analysis of variance: p less than 0.0001). Significant differences were observed between normals and diabetics without retinopathy (Scheffé test: p less than 0.0001), normals and diabetics with early retinopathy (Scheffé test: p less than 0.0001), no retinopathy and early retinopathy patients (Scheffé test: p less than 0.05). In diabetics without retinopathy multifactorial analysis of variance revealed a significant effect of age of onset of the disease (p less than 0.01) and an interaction effect between age of onset and duration (p less than 0.001) on PERG amplitude. These results suggest a possible use of the steady-state PERG to detect early macular dysfunction in insulin-dependent diabetics.

Entities:  

Mesh:

Year:  1989        PMID: 2638628     DOI: 10.1007/bf00155037

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  19 in total

Review 1.  The importance of measuring contrast sensitivity in cases of visual disturbance.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  1978-04       Impact factor: 4.638

2.  Human pattern-evoked electroretinogram.

Authors:  R F Hess; C L Baker
Journal:  J Neurophysiol       Date:  1984-05       Impact factor: 2.714

3.  Defective suppression of growth hormone after oral glucose loading in adolescence.

Authors:  G F Pieters; A G Smals; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

4.  Contrast sensitivity in diabetics with and without background retinopathy.

Authors:  S Sokol; A Moskowitz; B Skarf; R Evans; M Molitch; B Senior
Journal:  Arch Ophthalmol       Date:  1985-01

5.  Diabetic retinopathy. Assessment of severity and progression.

Authors:  B E Klein; M D Davis; P Segal; J A Long; W A Harris; G A Haug; Y L Magli; S Syrjala
Journal:  Ophthalmology       Date:  1984-01       Impact factor: 12.079

6.  The natural history of retinopathy in insulin-dependent juvenile-onset diabetes.

Authors:  P Palmberg; M Smith; S Waltman; T Krupin; P Singer; D Burgess; T Wendtlant; J Achtenberg; P Cryer; J Santiago; N White; C Kilo; W Daughaday
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

7.  Optic pathway conduction in insulin-dependent diabetics.

Authors:  F Ponte; M Anastasi; M Lauricella; G D Bompiani
Journal:  Doc Ophthalmol       Date:  1986-11-15       Impact factor: 2.379

8.  A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy.

Authors:  S G Coupland
Journal:  Doc Ophthalmol       Date:  1987-06       Impact factor: 2.379

9.  Color vision defects in early diabetic retinopathy.

Authors:  M S Roy; R D Gunkel; M J Podgor
Journal:  Arch Ophthalmol       Date:  1986-02

10.  The pattern evoked electroretinogram in optic neuritis. A combined psychophysical and electrophysiological study.

Authors:  G T Plant; R F Hess; S J Thomas
Journal:  Brain       Date:  1986-06       Impact factor: 13.501

View more
  33 in total

1.  Early distal axonopathy of the visual pathway in experimental diabetes.

Authors:  Diego C Fernandez; Laura A Pasquini; Damián Dorfman; Hernán J Aldana Marcos; Ruth E Rosenstein
Journal:  Am J Pathol       Date:  2011-11-10       Impact factor: 4.307

2.  Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema.

Authors:  Abdullah Ozkiris; Cem Evereklioglu; Ayse Oner; Kuddusi Erkiliç
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

Review 3.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 4.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

5.  Reversible dysfunction of retinal ganglion cells in non-secreting pituitary tumors.

Authors:  Lori M Ventura; Frank X Venzara; Vittorio Porciatti
Journal:  Doc Ophthalmol       Date:  2008-08-01       Impact factor: 2.379

6.  Study of Retinal Nerve Fibre Layer Thickness in Patients with Diabetes Mellitus Using Fourier Domain Optical Coherence Tomography.

Authors:  Renu Dhasmana; Sonal Sah; Neeti Gupta
Journal:  J Clin Diagn Res       Date:  2016-07-01

7.  ACE inhibition salvages the visual loss caused by diabetes.

Authors:  B V Bui; J A Armitage; M Tolcos; M E Cooper; A J Vingrys
Journal:  Diabetologia       Date:  2003-03-07       Impact factor: 10.122

8.  Pattern electroretinogram changes after intravitreal bevacizumab injection for diabetic macular edema.

Authors:  Abdullah Ozkiriş
Journal:  Doc Ophthalmol       Date:  2010-02-07       Impact factor: 2.379

9.  Visual evoked potentials after photostress in insulin-dependent diabetic patients with or without retinopathy.

Authors:  V Parisi; L Uccioli; G Monticone; L Parisi; G Menzinger; M G Bucci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

10.  Electrophysiological assessment of visual function in newly-diagnosed IDDM patients.

Authors:  L Uccioli; V Parisi; G Monticone; L Parisi; L Durola; C Pernini; R Neuschuler; M G Bucci; G Menzinger
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.